Literature DB >> 29632189

Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation.

Wanjing Shang1,2,3, Yong Jiang1,2,3, Michael Boettcher4, Kang Ding1,3,5, Marianne Mollenauer6,7, Zhongyi Liu1,2,3, Xiaofeng Wen8, Chang Liu1, Piliang Hao1, Suwen Zhao1,5, Michael T McManus4, Lai Wei9, Arthur Weiss10,7, Haopeng Wang11.   

Abstract

Despite decades of research, mechanisms controlling T cell activation remain only partially understood, which hampers T cell-based immune cancer therapies. Here, we performed a genome-wide CRISPR screen to search for genes that regulate T cell activation. Our screen confirmed many of the known regulators in proximal T cell receptor signaling and, importantly, also uncovered a previously uncharacterized regulator, FAM49B (family with sequence similarity 49 member B). FAM49B deficiency led to hyperactivation of Jurkat T cells following T cell receptor stimulation, as indicated by enhancement of CD69 induction, PAK phosphorylation, and actin assembly. FAM49B directly interacted with the active form of the small GTPase Rac, and genetic disruption of the FAM49B-Rac interaction compromised FAM49B function. Thus, FAM49B inhibits T cell activation by repressing Rac activity and modulating cytoskeleton reorganization.

Entities:  

Keywords:  FAM49B; Rac1; TCR signaling; actin cytoskeleton; genome-wide CRISPR screen

Mesh:

Substances:

Year:  2018        PMID: 29632189      PMCID: PMC5924929          DOI: 10.1073/pnas.1801340115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors.

Authors:  Gerd Prehna; Maya I Ivanov; James B Bliska; C Erec Stebbins
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

2.  The crystal structure of human rac1, a member of the rho-family complexed with a GTP analogue.

Authors:  M Hirshberg; R W Stockley; G Dodson; M R Webb
Journal:  Nat Struct Biol       Date:  1997-02

3.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

4.  Atp11p and Atp12p are assembly factors for the F(1)-ATPase in human mitochondria.

Authors:  Z G Wang; P S White; S H Ackerman
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

Review 5.  Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow.

Authors:  Rebekah L Gundry; Melanie Y White; Christopher I Murray; Lesley A Kane; Qin Fu; Brian A Stanley; Jennifer E Van Eyk
Journal:  Curr Protoc Mol Biol       Date:  2009-10

6.  Global profiling of co- and post-translationally N-myristoylated proteomes in human cells.

Authors:  Emmanuelle Thinon; Remigiusz A Serwa; Malgorzata Broncel; James A Brannigan; Ute Brassat; Megan H Wright; William P Heal; Anthony J Wilkinson; David J Mann; Edward W Tate
Journal:  Nat Commun       Date:  2014-09-26       Impact factor: 14.919

7.  T cell receptor signalling.

Authors:  J Lin; A Weiss
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

8.  Inhibition of the kinase Csk in thymocytes reveals a requirement for actin remodeling in the initiation of full TCR signaling.

Authors:  Ying Xim Tan; Boryana N Manz; Tanya S Freedman; Chao Zhang; Kevan M Shokat; Arthur Weiss
Journal:  Nat Immunol       Date:  2013-12-08       Impact factor: 25.606

9.  MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.

Authors:  Wei Li; Han Xu; Tengfei Xiao; Le Cong; Michael I Love; Feng Zhang; Rafael A Irizarry; Jun S Liu; Myles Brown; X Shirley Liu
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

10.  A CRISPR-Based Toolbox for Studying T Cell Signal Transduction.

Authors:  Shen Chi; Arthur Weiss; Haopeng Wang
Journal:  Biomed Res Int       Date:  2016-02-01       Impact factor: 3.411

View more
  32 in total

Review 1.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

Review 2.  The emerging regulatory roles of noncoding RNAs in immune function of fish: MicroRNAs versus long noncoding RNAs.

Authors:  Haitham G Abo-Al-Ela
Journal:  Mol Genet Genomics       Date:  2021-04-27       Impact factor: 3.291

Review 3.  Genome editing to define the function of risk loci and variants in rheumatic disease.

Authors:  Yuriy Baglaenko; Dana Macfarlane; Alexander Marson; Peter A Nigrovic; Soumya Raychaudhuri
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

4.  Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.

Authors:  Eric Shifrut; Julia Carnevale; Victoria Tobin; Theodore L Roth; Jonathan M Woo; Christina T Bui; P Jonathan Li; Morgan E Diolaiti; Alan Ashworth; Alexander Marson
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

5.  Estrogen-regulated AGR3 activates the estrogen receptor signaling pathway to promote tamoxifen resistance in breast cancer.

Authors:  Rui Jiang; Yongjie Sun; Xiao Chen; Peng Shi
Journal:  Breast Cancer Res Treat       Date:  2021-09-14       Impact factor: 4.872

Review 6.  Tumor immunology CRISPR screening: present, past, and future.

Authors:  Matthew B Dong; Kaiyuan Tang; Xiaoyu Zhou; Jingjia J Zhou; Sidi Chen
Journal:  Trends Cancer       Date:  2021-12-15

7.  In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer.

Authors:  Zeyu Chen; Eri Arai; Omar Khan; Zhen Zhang; Shin Foong Ngiow; Yuan He; Hua Huang; Sasikanth Manne; Zhendong Cao; Amy E Baxter; Zhangying Cai; Elizabeth Freilich; Mohammed A Ali; Josephine R Giles; Jennifer E Wu; Allison R Greenplate; Mohamed A Hakeem; Qingzhou Chen; Makoto Kurachi; Kito Nzingha; Viktoriya Ekshyyan; Divij Mathew; Zhuoyu Wen; Nancy A Speck; Alexis Battle; Shelley L Berger; E John Wherry; Junwei Shi
Journal:  Cell       Date:  2021-02-25       Impact factor: 41.582

Review 8.  Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer.

Authors:  Samantha M Fix; Amir A Jazaeri; Patrick Hwu
Journal:  Cancer Discov       Date:  2021-02-09       Impact factor: 39.397

Review 9.  CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring More.

Authors:  Xuejin Ou; Qizhi Ma; Wei Yin; Xuelei Ma; Zhiyao He
Journal:  Front Cell Dev Biol       Date:  2021-05-20

10.  CYRI-A limits invasive migration through macropinosome formation and integrin uptake regulation.

Authors:  Anh Hoang Le; Tamas Yelland; Nikki R Paul; Loic Fort; Savvas Nikolaou; Shehab Ismail; Laura M Machesky
Journal:  J Cell Biol       Date:  2021-06-24       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.